| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
49,250 |
3,733 |
$4.25M |
| A4657 |
Syringe, with or without needle, each |
3,074 |
2,186 |
$9K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
34,394 |
1,684 |
$448.02 |
| 90674 |
|
61 |
49 |
$22.93 |
| 82607 |
|
469 |
408 |
$0.00 |
| 82728 |
|
822 |
685 |
$0.00 |
| 83550 |
|
782 |
652 |
$0.00 |
| 82746 |
|
516 |
449 |
$0.00 |
| J1270 |
Injection, doxercalciferol, 1 mcg |
19,770 |
1,485 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
45 |
40 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
243 |
144 |
$0.00 |
| 83970 |
|
1,386 |
1,088 |
$0.00 |
| 83540 |
|
814 |
677 |
$0.00 |
| 85041 |
|
1,795 |
1,389 |
$0.00 |
| 85048 |
|
1,783 |
1,372 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
7,692 |
1,574 |
$0.00 |
| J0887 |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
491 |
201 |
$0.00 |